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Abstract
Background: Chagas disease is a neglected disease caused by the intracellular parasite Trypanosoma cruzi. Around 30% of
the infected patients develop chronic cardiomyopathy or megasyndromes, which are high-cost morbid conditions. Immune
response against myocardial self-antigens and exacerbated Th1 cytokine production has been associated with the
pathogenesis of the disease. As IL-17 is involved in the pathogenesis of several autoimmune, inflammatory and infectious
diseases, we investigated its role during the infection with T. cruzi.
Methodology/Principal Findings: First, we detected significant amounts of CD4, CD8 and NK cells producing IL-17 after
incubating live parasites with spleen cells from normal BALB/c mice. IL-17 is also produced in vivo by CD4
+, CD8
+ and NK
cells from BALB/c mice on the early acute phase of infection. Treatment of infected mice with anti-mouse IL-17 mAb
resulted in increased myocarditis, premature mortality, and decreased parasite load in the heart. IL-17 neutralization
resulted in increased production of IL-12, IFN-c and TNF-a and enhanced specific type 1 chemokine and chemokine
receptors expression. Moreover, the results showed that IL-17 regulates T-bet, RORct and STAT-3 expression in the heart,
showing that IL-17 controls the differentiation of Th1 cells in infected mice.
Conclusion/Significance: These results show that IL-17 controls the resistance to T. cruzi infection in mice regulating the
Th1 cells differentiation, cytokine and chemokine production and control parasite-induced myocarditis, regulating the influx
of inflammatory cells to the heart tissue. Correlations between the levels of IL-17, the extent of myocardial destruction, and
the evolution of cardiac disease could identify a clinical marker of disease progression and may help in the design of
alternative therapies for the control of chronic morbidity of chagasic patients.
Citation: Guedes PMdM, Gutierrez FRS, Maia FL, Milanezi CM, Silva GK, et al. (2010) IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in
Regulating Parasite-Induced Myocarditis. PLoS Negl Trop Dis 4(2): e604. doi:10.1371/journal.pntd.0000604
Editor: Rodrigo Correa-Oliveira, Rene ´ Rachou Research Center, Brazil
Received August 25, 2009; Accepted December 22, 2009; Published February 16, 2010
Copyright:  2010 Guedes et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), The Millennium Institute for Vaccine Development and
Technology (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jsdsilva@fmrp.usp.br
. These authors contributed equally to this work.
Introduction
Trypanosoma cruzi is an intracellular protozoan parasite that
causes Chagas’ disease, the major cause of infectious heart disease
in Latin America. It is estimated that 13 million people are
infected with T. cruzi in the Central and South America, and 75
million are at potential risk of infection (WHO, 2005). In non-
endemic countries, blood transfusions, organ transplantations,
and mother-to-child infection represent real risks for disease
transmission, due to high numbers of immigrants and the
autochthonous transmission of T. cruzi in the USA has been
reported [1]. During chronic phase, around 10% and 20% of
infected patients develop digestive (megaesophagus and megaco-
lon) and cardiac (cardiomegaly) form of Chagas disease,
respectively. The myocarditis that occurs as a result of infection
is thought to be due to parasites in the lesions, although immune-
mediated mechanisms also appear to be involved in heart
pathology [2]. Of note, the immune hyperactivity that is
deleterious to the host is governed by the imbalanced production
of cytokines in response to the parasite [3].
The pro-inflammatory cytokines IL-12, IFN-c, and TNF-a act
in concert to activate macrophages to kill the parasites through the
production of nitric oxide and nitrogen free radicals [4]. In
addition, these cytokines also stimulate the differentiation and
proliferation of Th1-biased CD4
+ T cells, which orchestrate a
CD8
+ T-cell response that causes tissue destruction and fibrosis
[5]. As expected, the inflammatory response is down-regulated by
the anti-inflammatory cytokines IL-10 and TGF-b [6,7], regula-
tory T cells [8–10], and CTLA-4
+ cells [11,12]. Lymphocytes of
patients with chronic chagasic cardiopathy (CCC) produce higher
amounts of IFN-c, TNF-a, and IL-6, but little or no IL-4 or IL-10
compared to asymptomatic individuals [3,13].
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the dichotomy of cytokines produced. However, the Th1-Th2
paradigm has been reconsidered following the discovery of a novel
lineage of effector CD4
+ T helper lymphocytes, called Th17 cells,
which produce interleukin 17 (IL-17)-A and F, IL-21, IL-22, and
TNF-a [14]. Th17 differentiation is thought to be mediated by the
combined effects of the transcription factors RORcta n dR O R a,
which are dependent on STAT-3, and requires IL-1b,I L - 6 ,I L - 2 1 ,
TGF-b, and the expression of the CCR6 chemokine receptor
[15,16]. In addition to Th17 cells, other cells produce IL-17,
including CD8
+ Tc e l l s ,cd T cells, neutrophils, monocytes, and NK
cells [17]. IL-17 has pro-inflammatory properties and induces
fibroblasts, endothelial cells, macrophages, and epithelial cells to
produce several inflammatory mediators, such as GM-CSF, IL-1,
IL-6, TNF-a, inducible nitric oxide synthase (iNOS) activation,
metalloproteinases, and chemokines (CXCL1, CXCL2, CXCL8,
CXCL10), leading to the recruitment of neutrophils and inflamma-
tion [18–20]. The Th17 response has been linked to the
pathogenesis of several inflammatory and autoimmune diseases,
such as multiple sclerosis, psoriasis, rheumatoid arthritis, colitis,
autoimmune encephalitis [21], schistosomiasis [22], and toxoplas-
mosis. Infection with T. cruzi also leads to the production of several
chemokines and cytokines [23] as well as iNOS [4] and
metalloproteinase activation [24]. Also, lymphocytes from infected
mice and chagasic patients recognize self-epitopes [2], suggesting a
possible autoimmune response. Altogether, these observations
suggest the possible involvement of IL-17 in the pathogenesis of
T. cruzi infection. Therefore, we investigated IL-17 production in T.
cruzi-infected mice and its role in the modulation of the immune
response. Our results show that IL-17 is produced during the acute
phase of T. cruzi infection and controls cardiac inflammation by
modulating the Th1 response.
Methods
Animals, parasites, and experimental infection
BALB/c female mice, 6 weeks old, were cared for according to
institutional ethical guidelines and the Ethics Committee in Animal
Research of the FMRP-USP approved all experimental protocols.
Mice were infected via the i.p. route with 100 blood trypomastigotes
of T. cruzi,Ys t r a i n .F o rin vitro experiments, the trypomastigotes
were grown and purified from a fibroblast cell line (LLC-MK2).
Treatment of mice with mAb against IL-17
Balb/c mice were treated one day before inoculation, and on
days four and eight with i.p. injections of 100 mg of normal rat IgG
or rat anti-mouse IL-17 (IgG2a, clone M210, Amgen, Seattle,
WA). Parasitemia was measured in 5 mL of blood obtained from
the tail vein, and mortality was evaluated with five mice per
treatment group. Sera, heart tissue, livers, and spleens were
collected 14 days p.i from five infected and treated mice.
Splenocyte cultures
To determine if the parasite induces IL-17 production, naive
splenocytes (5610
6 cells/ml) from Balb/c mice were cultured for
48 h with trypomastigotes (2.5610
7/ml) in 48-well plates (final
volume of 0.5 ml) and intracellular IL-17A in CD4
+, CD8
+, and
NK cells was determined. To shed light on the mechanism that
controls IL-17 production, splenocytes (1610
6 cells/ml) from
normal or T. cruzi-infected Balb/c mice (14 days p.i.) were
cultured with Con-A (5 mg/ml) (Sigma-Aldrich, St. Louis) and T.
cruzi antigen (10gg/well), with or without antibodies against IL-17
or IFN-c (IgG1, clone R46A2) (10 mg/well), and cytokine
production was determined.
Cytokine quantification (ELISA)
Cytokine production was assayed in sera, tissue heart, liver, and
spleen. Tissue fragments were added to vials containing PBS
(50 mg/ml) with a protease inhibitor cocktail (Complete, Roche).
The tissue fragments were macerated, centrifuged, and the
supernatants collected for cytokine quantification. The ELISA sets
were IL-1b, IL-4, IL-6, IL-10, IL-12, IL-17, IL-25, IFN-c,T N F - a,
and TGF-b (R&D, Minneapolis, MN), and procedures were
performed according to the manufacturers’ instructions. Optical
densities were measured at 450 gm. Results are expressed as
picograms per milliliter. The limits of sensitivity for the different
assays were as follows: IL-4, IL-17, IL-10, TGF-b and TNF-a:
15 pg/ml; IL-12: 10 pg/ml; IFN-c:5 0p g / m l ,I L - 1 b: IL-25 and IL-
6: 20 pg/ml.
Isolation of leukocytes from cardiac tissue
To isolate mononuclear cells from myocardial tissues, the hearts
from five mice were removed at 14 days post infection (p.i.),
washed (to remove blood clots), pooled, minced with scissors into
small fragments, extensively washed, and subjected to enzymatic
digestion with a 500 mg/ml liberase solution (Roche Applied
Science, Indianapolis, IN) for 30 min at 37uC. The tissues were
processed with RPMI 10% FCS and 0,05% DNAse (Sigma-
Aldrich) using Medmachine (BD) for 4 min, the cell suspension
was spun, the supernatant removed, and the pellet suspended in
RPMI 10% FCS. Suspensions of total spleen cells were washed
and the leukocyte purification from these samples and from cardiac
cells was done in Ficoll Hypaque (d=1077 g/ml, Sigma - Aldrich)
gradient by centrifuging at 4006g by 30 min at room temperature.
The leukocytes obtained were evaluated by flow cytometry.
Intracellular cytokine detection
The expression of IL-17 and IFN-c in leukocytes (1610
6/well)
from heart and spleen were assayed after incubation with
monensin (2 mg/ml) for 6 h in RPMI 1640 supplemented with
fetal bovine serum (10%). The cells were washed in cold PBS and
samples of 5610
5 cells/tube were incubated for 30 min at 4uC
with 0.5 mg of anti-CD16/CD32 mAb (FC block), followed by the
Author Summary
Chagas disease is caused by the intracellular parasite
Trypanosoma cruzi. This infection has been considered one
of the most neglected diseases and affects several million
people in the Central and South America. Around 30% of
the infected patients develop digestive and cardiac forms
of the disease. Most patients are diagnosed during the
chronic phase, when the treatment is not effective. Here,
we showed by the first time that IL-17 is produced during
experimental T. cruzi infection and that it plays a
significant role in host defense, modulating parasite-
induced myocarditis. Applying this analysis to humans
could be of great value in unraveling the elements
involved in the pathogenesis of chagasic cardiopathy
and could be used in the development of alternative
therapies to reduce morbidity during the chronic phase of
the disease, as well as clinical markers of disease
progression. The understanding of these aspects of disease
may be helpful in reducing the disability-adjusted life years
(DALYs) and costs to the public health service in
developing countries.
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CD3, CD4, CD8, or PanNK (all from BD Pharmingen, San
Diego, CA) for an additional 30 minutes at 4uC in the dark. To
detect intracellular IL-17 and IFN-c, the cells were fixed with
cytofix and cytoperm solution for 15 min at room temperature,
washed, and then stained with FITC- or PE-labeled antibodies at
4uC in the dark and incubated overnight. Subsequently, the cells
were washed twice and suspended in 200 mL of PBS/1%
formaldehyde. For each assay 50,000 events were acquired and
data acquisition was performed using a FACSorter. Multivariate
data analysis was performed using FlowJo software. The data was
exported from the histogram and were processed in Prism
Software for statistical analysis and graphics.
Cardiac parasitism
DNA from the hearts of mice at 14 days p.i. was purified using the
SV Total DNA Isolation System kit (Promega, Madison, WI)
according to the manufacturer’s instructions. Real-time PCR was
performed using the Platinum SYBR Green qPCR SuperMix UDG
with ROX reagent (Invitrogen, Carlsbad, CA) with 100 gg of total
gDNA. The sequences of primers used were TCZ-F 59-GCT CTT
GCC CAC AMG GGT GC-39 and TCZ-R 59-CCAAGCAGCG-
GATAGTTCAGG-39. The samples were amplified in a thermal
cycler ABI PRISM 7000 Sequence Detection System (Applied
Biosystems, Foster City, CA) with the following PCR conditions: first
step (2 min at 50uC ) ,s e c o n ds t e p( 1 0m i na t9 5 uC) and 40 cycles (30 s
at 95uC, 30 s at 60uC, and 1 min at 72uC), followed by a dissociation
stage. The results were based on a standard curve constructed with
DNA from culture samples of T. cruzi trypomastigotes (n=3).
T-bet, GATA-3, Foxp3, STAT-3, RORct, and chemokine
mRNA expression
Total RNA from cardiac tissue was isolated using the TRIZOL
reagent (Invitrogen) and SV Total RNA Isolation System (Promega,
Madison, WI) according to the manufacturers’ instructions. cDNA
was synthesized using 1 mg of tRNA through a reverse transcription
reaction (ImProm-II
TM Reverse Transcriptase, Promega). Real-time
PCR quantitative mRNA analyses were performed in an ABI Prism
7000 SDS (Applied Biosystems) using the Platinum SYBR Green
qPCR SuperMix UDG with ROX reagent (Invitrogen) for
quantification of amplicons. The standard PCR conditions were as
follows: 50uC( 2m i n ) ,9 5 uC( 1 0m i n ) ;4 0c y c l e so f9 4 uC( 3 0s ) ,5 8 uC
(30 s), and 72uC (1 min); followed by a standard denaturation curve.
The sequences of primers were designed using the Primer Express
software package (Applied Biosystems) utilizing nucleotide sequences
present in the GenBank database (Table 1). Platinum SYBR Green
qPCR SuperMix UDG with ROX reagent (Invitrogen), 1 mg/mlo f
each specific primer, and a 1:20 dilution of cDNA were used in each
reaction. The mean Ct values from triplicate measurements were
used to calculate expression of the target gene, with normalization to
an internal control (b-actin) using the 2
–DCt formula.
Quantification of heart infiltrating cells
The total number of nucleated cells was counted in fifty
microscopic fields in at least four representative, nonconsecutive,
HE-stained sections (5 mm thickness) from each mouse. Sections
were examined using a Zeiss Integrationsplatte II eyepiece (Zeiss
Co, Oberkochen, Germany) reticule, using a microscope at a final
magnification of 400X.
Statistical analysis
Data are expressed as means 6 SEM. Student’s t test was used
to analyze the statistical significance of the observed differences in
infected vs. control assays. In time course studies, one-way
ANOVA was used followed by Tukey-Kramer post-hoc analysis.
The Kaplan-Meier method was used to compare survival curves of
the studied groups. All analyses were performed using PRISM 3.0
software.
Table 1. Primer sequences and reaction properties.
Target Sense and Antisense Sequences bp
B-actin AGC TGC GTT TTA CAC CCT TT 81
AAG CCA TGC CAA TGT TGT CT
Foxp3 ACA ACC TGA GCC TGC ACA AGT 155
GCC CAC CTT TTC TTG GTT TTG
T-Bet CCC ACA AGC CAT TAC AGG ATG 125
TAT AAG CGG TTC CCT GGC ATG
GATA-3 AGG AGT CTC CAA GTG TGC GAA 165
TTG GAA TGC AGA CAC CAC CT
STAT-3 GCC ACG TTG GTG TTT CAT AAT 58
GGA ATC GGC TAT ATT GCT GGT
RORct TGG AAG ATG TGG ACT TCG TTT 55
TGG TTC CCC AAG TTC AGG AT
CCR3 GCT CTC TGG ATT GAA GTG TGC A 82
AAG TAT CAC GTC CAC CAC CTG G
CCR4 CGA TTC CAA AGA TGA ATG CCA 127
TCC CCA AAT GCC TTG ATA CC
CCR5 TGC ACA AAG AGA CTT GAG GCA 191
AGT GGT TCT TCC CTG TTG GCA
CCR6 GCC CAG CAC ATC ATA GCA TT 52
CCA GGA TTT GTA AGT TGC CC
CCL2 AGG ACA GAT GTG GTG GGT TT 53
TGC AGC AGT CAA CAC AAA TTG
CCL3 TTC TGC TGA CAA GCT CAC CCT 117
ATG GCG CTG AGA AGA CTT GGT
CCL4 CCT GAC CAA AAG AGG CAG ACA 169
AGC AAG GAC GCT TCT CAG TGA
CCL5 TTC CCT GTC ATC GCT TGC TCT 101
CGG ATG GAG ATG CCG ATT TT
CCL11 AGA TGC ACC CTG AAA GCC AT 107
TTT GGT CCA GGT GCT TTG TG
CCL17 GAA GTC CCT GTT CCC TTT TTT 57
TGT GTT CGC CTG TAG TGC ATA
CCL20 TTT GGG ATG GAA TTG GAC AC 51
ACC CCA GCT GTG ATC ATT TC
CCL22 ATG GTG CCA ATG TGG AAG A 68
TAA ACG TGA TGG CAG AGG GT
CXCL9 AAT TTC ATC ACG CCC TTG AGC 90
CAG CTG TTG TGC ATT GGA TAG C
CXCL10 AGC GTT TAG CCA AAA AAG GTC 51
TGG CTT CAC TCC AGT TAA GGA
T. cruzi GCT CTT GCC CAC AMG GGT GC 195
CCA AGC AGC GGA TAG TTC AGG
bp: base pairs of amplicon size.
doi:10.1371/journal.pntd.0000604.t001
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T. cruzi induces IL-17 production
First, we evaluated IL-17 production by spleen cells from naive
mice incubated with live trypomastigotes. We found that the
percentage of IL-17
+ splenocytes in cultures containing T. cruzi
(13.8664.59%) was higher than in the controls (5.4562.87%)
(Figure 1A). The mean fluorescence intensities of intracellular IL-
17 staining in the absence (6.0261.15) and presence of parasites
(11.2961.54) indicated that culture with parasites increased the
Figure 1. Trypomastigotes of T. cruzi induce IL-17 production by mouse splenocytes in vitro. Leukocytes from BALB/c mice (5610
6 cells/
ml) were cultured with or without trypomastigotes (2.5610
7/ml) of T. cruzi for 48 hours and the intracellular expression of IL-17 determined in total
splenocytes (A), CD4
+, CD8
+, and NK cells (B) (mean 6 SEM of cultures in triplicate, 3 animals/group). In A, the empty histograms represent IL-17
+
cells harvest from cultures in the presence (black line) or absence of parasites (gray line) and the full histogram represents an IgG FITC control. The
data are representative of two independent experiments. * P,0.05 compared to uninfected mice.
doi:10.1371/journal.pntd.0000604.g001
Figure 2. Trypanosoma cruzi infection induces IL-17 expression in mouse splenocytes. The ex vivo frequencies of IL-17
+ cells were
determined in total splenocytes (A) of BALB/c mice on 0, 7, 14, and 21 days p.i.. In B and C, the percentage (mean 6 SEM) of IL-17
+ lymphocytes and
CD4
+, CD8
+, NK cells of mice on day 14 p.i. are shown. The data are representative of two independent experiments with 3 mice in each day of
infection. * P,0.05 compared to uninfected mice.
doi:10.1371/journal.pntd.0000604.g002
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CD4
+ and CD8
+ T lymphocytes as well as NK cells (Figure 1B).
IL-17
+ cells were significantly increased in spleens of mice during
the course of acute infection (Figure 2A). The percentage of IL-17
+
lymphocytes on day 14 p.i. was also significantly increased
compared with uninfected control mice (Figure 2B). On day 14
p.i., the main IL-17
+ lymphocytes were CD4
+ (4.7960.87)
followed by CD8
+ T cells (1.9260.79) (Figure 2C). These results
clearly indicate that infection with T. cruzi leads to IL-17
production.
Blockade of IL-17 increases susceptibility to T. cruzi
infection
Since IL-17 is produced during the acute phase of T. cruzi
infection, we investigated its role in parasite control. We treated
mice with anti-IL-17 neutralizing antibody and evaluated the
course of infection and mortality. We did not find significant
differences in the course of parasitemia of anti-IL-17 treated mice
compared with the control group (Figure 3A). However, there was
a significant reduction in cardiac parasitism of anti-IL-17 treated
mice (day 14 p.i.) compared with infected mice treated with
normal rat IgG (Figure 3B). Importantly, infected mice treated
with anti-IL-17 exhibited significantly earlier mortality compared
to controls. The anti-IL-17 treated mice survived only until day 18
p.i., whereas the control group survived until 24 days p.i.
(Figure 3C). Inhibition of IL-17 also resulted in more inflamma-
tory cells in the heart tissue of T. cruzi-infected mice on day 14 p.i.
(Figure 4A and B). The total number of nuclei per 50 mm section
of heart tissue was higher in infected mice treated with anti-IL-17
(677.25689.36) than in controls (439.75654.87) (Figure 4A). It is
noteworthy that by microscopy analysis, the inflammatory
infiltrate found in all infected mice was characterized by
mononuclear cells, and scarce presence of polymorphonuclear
cells, and no difference were detected in the cellular composition
of the myocarditis between the groups at day 14 pi. We conclude
that IL-17 plays a role in resistance to the infection, modulating
the inflammatory reaction that occurs in infected mice.
Cytokine production in T. cruzi-infected mice treated
with anti-IL-17
To investigate the mechanism by which IL-17 neutralization
changes the course of infection, we first compared cytokine
production in T. cruzi-mice treated or not with anti-IL-17. As
expected, we detected significant levels of IFN-c, TNF-a, IL-10,
and IL-12 in the sera and tissue heart of T. cruzi-infected mice
(Figure 5). Inhibition of IL-17 resulted in significantly higher levels
of IFN-c and IL-12 in the sera and heart tissue, and increased
TNF-a level in the heart tissue of infected mice compared with
mice treated with normal rat IgG. Treatment with anti-IL-17 did
not, however, change the levels of IL-10. IL-17 was not detected in
the sera but, consistent with previous results, infection increased
IL-17 levels in the heart tissue (Figure 5), where it was produced by
CD4
+, CD8
+ and NK cells (Figure 6A). Again, treatment with anti-
IL-17 decreased IL-17 levels (Figure 5) and production by CD4
+
Figure 3. Enhanced cardiac parasitism and mortality in T. cruzi infected mice treated with anti-IL-17. Parasitemia (A), cardiac parasitism
(B), and survival (C) were determined in mice infected with T. cruzi. The quantification of genomic DNA was determined by real time PCR on tissue
heart of mice on day 14 p.i. The data (mean 6 SEM) are representative of two independent experiments (five mice per group). * P,0.05 compared to
infected mice treated with normal rat IgG.
doi:10.1371/journal.pntd.0000604.g003
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+ cells in the heart (Figure 6A), and increased IFN-c
production by CD4
+ cells (Figure 6B). IL-17 neutralization did not
changed the frequency of CD4
+ (29.3262.14 vs 24.3761.87%),
CD8
+ (52.0165.38 vs 43.5262.90%) and NK (0.760.12 vs
1.0160.19%) cells in the heart. Low levels of IL-25 were detected
in the heart tissue and spleens of normal mice, but not in infected
mice. IL-1b, IL-4, IL-6, and TGF-b were detected in the sera,
myocardium, spleens, and livers of T. cruzi-infected mice, but did
not change with anti-IL-17 treatment (data not shown).
IL-17 controls IFN-c and TNF-a during the acute phase of
T. cruzi infection
Next, we investigated the mechanisms that regulate IL-17
production and the means by which IL-17 modulates Th1
cytokine production. IL-17 was detected only when leukocytes
from normal or infected mice were cultured with Con-A, and it
was significantly increased when endogenous IFN-c was inhibited
(Figure 7). IL-12, IFN-c, and TNF-a production by leukocytes
from acutely infected mice were also regulated by IL-17, as
addition of anti-IL-17 to the cultures significantly increased the
production of these cytokines in the presence of parasite antigen.
In the presence of mitogen, we found increased production of IL-
12 and IFN-c by the addition of anti-IL-17 (Figure 7). These
results show that IL-17 produced during T. cruzi infection
modulates IFN-c, TNF-a, and IL-12 production.
IL-17 neutralization during T. cruzi infection increases Th1
responses
To understand how IL-17 regulates the pattern of cytokine
production, we examined the expression of the transcription factors
Foxp3, T-bet, GATA-3, and STAT-3/RORct. T. cruzi infected mice
showed enhanced of Foxp3, T-bet, GATA-3, STAT-3, and RORct
Figure 4. IL-17 neutralization increases T. cruzi-induced heart
pathology. Quantification of nuclei (A) in the heart tissue of normal
mice (white bar) and infected mice (14 days p.i.) treated with normal rat
IgG (gray bar) or with anti-IL-17 (black bar). In (B), representative
microphotographs (original magnification 6400) of cardiac tissue of
mice on day 14 post T. cruzi infection are shown. Data (mean 6 SEM)
are representative of two independent experiments using five mice per
group. * P,0.05 compared to infected mice treated with normal rat IgG.
doi:10.1371/journal.pntd.0000604.g004
Figure 5. IL-17 controls IFN-c, TNF-a, IL-12, and IL-17 produc-
tion in heart tissue of mice infected with T. cruzi. IFN-c, TNF-a, IL-
10, IL-12, and IL-17 were quantified in the sera and heart tissue of
infected mice (14 days p.i.) that were treated or not with anti-IL-17. For
heart cytokine quantification, 50 mg of tissue was homogenized in
1.0 ml of PBS plus protease inhibitors. The data (mean 6 SEM) are
representative of two independent experiments (five mice per group).
* P,0.05 compared to infected mice treated with normal rat IgG.
doi:10.1371/journal.pntd.0000604.g005
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IL-17 neutralization in T. cruzi-infected mice significantly increased T-
bet but decreased STAT-3 and RORct mRNA expression in the
heart when compared to infected control animals (Figure 8A).
Concomitant to the enhanced expression of the Th1 transcription
factor (T-bet) and reduction of Th17 transcription factors (STAT-3
and RORct), the cardiac tissue of IL-17 neutralized mice exhibited
higher expression of CCR5, and decreased expression of CCR3 and
CCR4 chemokine receptors, both involved in Th2 and regulatory T
cell migration [25,26]. The expression of CCR6, a chemokine
receptor expressed by Th17 cells, was markedly reduced in the heart
tissue of T. cruzi infected mice treated with anti-IL-17 (Figure 8B). The
expression of CCL2, CCL3, CCL4, CCL11, and CXCL9, which are
involved in T-cell migration to the heart tissue of infected mice, but
not CCL5, CCL17, CCL22, or CXCL10, was increased in the heart
tissue of anti-IL-17 treated mice (Figure 8C). Therefore, IL-17 inhibits
T-bet and Th1 chemokine expression in the heart tissue of T. cruzi
infected mice.
Discussion
The results shown here demonstrate that T. cruzi infection
results in the production of IL-17, which regulates the immune
response as well as the development of heart lesions during the
course of infection. Moreover, IL-17 regulates the expression of
the transcription factors T-bet, RORct, and STAT-3, the
production of inflammatory cytokines and chemokines, and the
expression of their receptors in the heart. First, we showed that
trypomastigotes induce IL-17 production by CD4
+,C D 8
+, and
NK cells from naı ¨ve mice, and that an increased number of IL-
17
+ cells is observed during the acute phase of infection. Low IL-
17 production was previously described for splenic CD4
+ T cells
from infected mice cultured with T. cruzi antigen [27]. In vivo the
amount of leukocytes expressing IL-17 is very relevant, mainly if
we consider that the number of lymphocytes increase dramati-
cally during the infection [28]. The mechanism by which the
parasites can trigger IL-17 production is unknown, but it could
involve antigen recognition by pathogen associated pattern
receptors. Parasite compounds lead to the production of IL-12
[29], TNF-a [30], and IL-10 [31], and they activate TLR2 [32],
TLR4 [33], and TLR9 [34]. The glycoinositolphospholipid from
T. cruzi is a TLR4 agonist with proinflammatory effects [35], and
TLR4 activation is important for Th17 cell survival through the
induction of IL-23 production by dendritic cells [36]. Moreover,
mice deficient in TLR4 have markedly lower numbers of Th17
cells and a reduced capacity to produce IL-17 in an experimental
model of arthritis [37]. IL-17 production and Th17 differentia-
tion can be induced by IL-1b, IL-6, and TGF-b[15], which are
all produced during T. cruzi infection [7,38,39]. Additionally, the
phagocytosis of apoptotic leukocytes [40], a frequent occurrence
in T. cruzi-infected mice [41], induces TGF-b synthesis [7,42] and
IL-6 production [39], thereby setting the stage for Th17
differentiation. Thus, it is possible that IL-17 production and
Th17 driving do occur early after innate immune recognition of
T. cruzi. We are currently performing additional experiments to
study the possible role of TLR2 and TLR4 in T. cruzi-driven IL-
17 production showed herein. Since trypomastigotes induced IL-
17 production by spleen cells in vitro, it is possible that other
strains with different tropism also induce similar amount of this
cytokine production. However, this important question has to be
addressed.
Neutralization of IL-17 using an anti-IL-17 monoclonal
antibody [43] did not change the parasitemia of T. cruzi-infected
mice but resulted in decreased parasitism in heart tissue, and led to
earlier mortality. As the Y strain is infective to several cell types,
many tissues besides heart can act as parasite reservoirs and
consequently can contribute to the peripheral blood parasitemia.
IL-17 neutralization also resulted in increased production of IFN-c
and TNF-a in tissues and sera; both cytokines are known to
activate macrophages to produce nitric oxide and promote the
killing of intracellular amastigotes [4]. In fact, neutralization of IL-
17 resulted in significantly less parasite DNA in the heart tissue,
probably due to an increase in iNOS production (data not shown).
Unlike in rheumatoid arthritis, colitis, and autoimmune enceph-
alitis (EAE) [21], where IL-17 induces and sustains inflammation,
in T. cruzi infection, IL-17 exhibits a regulatory effect. Some Th17
cells generated via TGF-b and IL-6 [15], cytokines produced
during T. cruzi infection [7,39], produce high levels of IL-10 and
prevent lesions in EAE [44], consistent with our data suggesting an
anti-inflammatory role for IL-17. In accordance, scarce neutro-
phils were found in the inflammatory substrate of heart of T. cruzi-
infected mice, independent of treatment or not with anti-IL-17.
Our data also show that IL-17 controls IFN-c production, as
previously observed in mice with EAE [45].
To further understand the regulatory effects of IL-17, cultures of
spleen cells from normal or infected mice were treated with anti-
IL-17. As observed in vivo, the cells exhibited increased
intracellular expression of IL-12, IFN-c, and TNF-a, confirming
Figure 6. IL-17 controls Th1 differentiation in T. cruzi-infected
mice. BALB/c mice were infected, the heart harvested on day 14 p.i.,
the leukocytes isolated and incubated with monensin for 6 h in culture
medium, and the intracellular expression of IL-17 (A) and IFN-c (B) were
determined. Data (mean 6 SEM) are representative of two independent
experiments using five mice per group. * P,0.05 compared to infected
mice treated with normal rat IgG.
doi:10.1371/journal.pntd.0000604.g006
IL-17 Controls T. cruzi-Induced Myocarditis
www.plosntds.org 7 February 2010 | Volume 4 | Issue 2 | e604a regulatory role for IL-17 in the immune response of T. cruzi
infected mice. Since a high level of IFN-c and TNF-a production
can generate undesirable side effects [11,30,31], IL-17 could be
important in modulating these cytokines during acute T. cruzi
infection, resulting in fewer heart lesions and delayed mortality.
The increased IFN-c production observed in mice treated with
anti-IL-17 could be due to enhanced IL-12 secretion and
increased T-bet expression, a transcription factor crucial for Th1
differentiation [46]. Therefore, IL-17 seems to act indirectly on the
differentiation of Th1 lymphocytes through the control of IL-12
production. In contrast, the expression of RORct and STAT-3,
which lead to Th17 differentiation [15], were decreased in infected
mice treated with anti-IL-17. Analogous to Th1 and Th2 cell
responses, Th17 cell responses are amplified by a positive feedback
loop [47]. The expression of GATA-3, a Th2 transcription factor
[48], remained unchanged. Of note, T. cruzi infection induces
markedly increased expression of RORct and STAT-3, clearly
indicating the induction of Th17 differentiation.
Figure 7. Cross-regulation of IL-12, IFN-c, and IL-17 during T. cruzi infection. Splenocytes from BALB/c mice infected (14 days p.i.) or not
with T. cruzi were harvested, cultured for 72 hours with or without Con-A (5 mg/ml), T. cruzi antigen (10 gg/well), anti-IL-17 (10 mg/well) or anti-IFN-c
(10 mg/well). The cytokines IL-17, IL-12, IFN-c, and TNF-a were determined by ELISA. The data show the mean 6 SEM of triplicate cultures with 3 mice
per group and are representative of two independent experiments. * P,0.05 compared to control culture.
doi:10.1371/journal.pntd.0000604.g007
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modulation of the migration of inflammatory cells to the heart
tissue of infected mice. Chemokines, including the ligands of
CCR5 [49] and CCR2 [50,51], are important to the mechanism
that leads to myocarditis. In the hearts of mice treated with anti-
IL-17, we found increased expression of CCL2, CCL3, CCL4,
CXCL9, and CCL11, which, except for the last, clearly favor the
Th1 type response. As the expression of chemoattractants is under
the control of IFN-c and TNF-a, it is possible that increased IFN-c
and TNF-a production, as a result of IL-17 neutralization and
elevated IL-12 production, is responsible for the increased
myocarditis. Accordingly, we found decreased expression of
CCR3 (a Th2-associated receptor) and increased expression of
CCR5, a receptor crucial for the development of myocarditis [49].
This may explain the decrease in heart tissue parasitism, since the
chemokines CCL2, CCL3, CCL4, CCL5, and CXCL9 as well as
IFN-c can induce iNOS activation in macrophages and cardiac
myocytes [51,52]. Also, since CCR4 and CCR6, but not CCR5,
are expressed by Th17 cells [53], the decreased expression of
CCR4 and CCR6 but increased expression of CCR5 clearly
indicates a reduction in Th17 cells in the inflammatory lesions,
confirming that treatment with anti-IL-17 was effective.
In summary, our results show that IL-17 plays a role in the
pathogenesis of T. cruzi-induced myocarditis. We propose that IL-
17 elicited during the infection reduces IL-12 production and T-
bet expression, which, as a consequence, decreases the production
of IFN-c, TNF-a, and chemokines. Therefore, IL-17 controls Th1
differentiation in T. cruzi-infected mice. The role of IL-17 in the
pathogenesis of Chagas’ disease is a question that deserves further
investigation. Correlations between the levels of IL-17, the extent
of myocardial destruction, and the evolution of cardiac disease
could identify a clinical marker of disease progression and may
help in the design of alternative therapies for the control of chronic
morbidity of chagasic patients.
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